The long-term goal of the principal investigator is to devise therapeutic strategies for the manipulation of pulmonary alveolar repair after lung injury. Repair of damaged alveolar epithelium,is accomplished through the proliferation and differentiation of type II pneumocytes, which replace lost type I or type II epithelial cells. The efficiency of these processes is now believed to be a critical determinant in the development of pulmonary fibrosis. In recent collaborative work, the applicant found evidence that lung fibroblasts, isolated from patients or experimental animals with fibrotic lung injury, produce a factor(s) capable of inducing apoptosis and necrosis of alveolar epithelial cells of either human or rat origin. The nature of this phenomenon in vitro suggests a mechanism for the generation of the """"""""cuboidal epithelium"""""""" of the fibrotic lung: it is hypothesized that fibroblast-derived factors kill type I pneumocytes at a rate faster than that of type II cell division. This project will test that theory through the application of experiment techniques and working hypotheses developed in the applicant's earlier PHS-funded work.
In Specific Aim 1, type II cell kinetics during the development of the cuboidal epithelium will be carefully characterized to determine the plausibility of such a mechanism. This will be accomplished through the application of the principal investigator's unique flow cytometric approaches to an established rat model of diffuse interstitial pulmonary fibrosis, from which the lung fibroblasts mentioned above were derived.
In Specific Aim 2, the precise actions of the fibroblast-derived factor(s) on type II cell division, differentiation and death will be quantitated through lung epithelial cell culture systems established in the applicants laboratory.
In Specific Aim 3 these measurements will be related to in situ studies of human and rat lung tissue. The fibroblasts synthesizing the active factor(s) will be characterized in Specific Aim 4, and the factor itself will be identified in Specific Aim 5. This project will clarify our understanding of a poorly understood, but common phase of lung injury, the """"""""cuboidal epithelium"""""""" of later stage lung injuries which lead to pulmonary fibrosis. The proposed experiments will elucidate a previously unrecognized mechanism of lung pathophysiology, and will result in the identification of paracrine pathways and molecules which contribute to the pathogenesis of fibrotic lung diseases. This knowledge will serve as the foundation for future work to design therapeutic interruptions of this mechanism for the improved management of lung disease.
|Abdul-Hafez, Amal; Mohamed, Tarek; Omar, Hanan et al. (2018) The renin angiotensin system in liver and lung: impact and therapeutic potential in organ fibrosis. J Lung Pulm Respir Res 5:|
|Ota, C; Gopallawa, I; Ivanov, V et al. (2017) Protection of Meconium-Induced Lung Epithelial Injury by Protease Inhibitors. J Lung Pulm Respir Res 4:|
|Gopallawa, Indiwari; Uhal, Bruce D (2016) Angiotensin-(1-7)/mas inhibits apoptosis in alveolar epithelial cells through upregulation of MAP kinase phosphatase-2. Am J Physiol Lung Cell Mol Physiol 310:L240-8|
|Gandhi, Chintan; Uhal, Bruce D (2016) Roles of the Angiotensin System in Neonatal Lung Injury and Disease. JSM Atheroscler 1:|
|Abdelwahab, Abdellatif; Gopallawa, Indiwari; Piasecki, Christopher C et al. (2016) Bleomycin-Induced Neonatal Lung Injury Requires the Autocrine Pulmonary Angiotensin System. Jacobs J Pulmonol 2:|
|Mohamed, Tarek L; Nguyen, Hang T; Abdul-Hafez, Amal et al. (2016) Prior hypoxia prevents downregulation of ACE-2 by hyperoxia in fetal human lung fibroblasts. Exp Lung Res 42:121-30|
|Oarhe, Chinyere I; Dang, Vinh; Dang, MyTrang et al. (2015) Hyperoxia downregulates angiotensin-converting enzyme-2 in human fetal lung fibroblasts. Pediatr Res 77:656-62|
|Gopallawa, Indiwari; Uhal, Bruce D (2014) Molecular and cellular mechanisms of the inhibitory effects of ACE-2/ANG1-7/Mas axis on lung injury. Curr Top Pharmacol 18:71-80|
|Dang, My-Trang T; Gu, Chenyang; Klavanian, Jeannie I et al. (2013) Angiotensinogen promoter polymorphisms predict low diffusing capacity in U.S. and Spanish IPF cohorts. Lung 191:353-60|
|Uhal, Bruce D; Dang, MyTrang; Dang, Vinh et al. (2013) Cell cycle dependence of ACE-2 explains downregulation in idiopathic pulmonary fibrosis. Eur Respir J 42:198-210|
Showing the most recent 10 out of 16 publications